Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.

A new regulatory region (-108 to -86), named CE, containing potential CRE- and Ets-binding sites has been identified in the murine E-cadherin promoter. The Ets-binding site (at -97 position) negatively modulates the activity of the E-cadherin promoter in expressing keratinocyte cell lines and was responsible for the specific retarded complexes obtained with the CE region. Analysis of the methylation status of the endogenous E-cadherin promoter indicated that silencing of E-cadherin expression in malignant keratinocytes cannot be explained by hypermethylation mechanisms. Furthermore, treatment with 5'-aza-2'-deoxycytidine was unable to induce the expression of E-cadherin in deficient keratinocytes. However, in vivo footprinting analysis of the endogenous E-cadherin promoter showed a very distinct pattern in expressing and nonexpressing keratinocytes. Extensive interactions in the previously postulated proximal regulatory elements and in the CE region were detected in expressing cells, while only some nucleotides of the E-pal element and of the CE region were protected in nonexpressing keratinocytes. These results indicate a complex regulation of the mouse E-cadherin promoter and support a model where the combination of positive (CCAAT-box and GC-rich region) and negative (E-pal element and CE region) cis-acting elements contribute to the final level of E-cadherin gene expression. In addition, our results show that downregulation of E-cadherin expression in transformed epidermal keratinocytes is mainly exerted through the interaction of repressor factor(s) with the E-pal element and to the lack of interaction of positive acting factors with the proximal regions.

[1]  Y. De Launoit,et al.  Requirement of a GT Box (Sp1 Site) and Two Ets Binding Sites for Vascular Endothelial Cadherin Gene Transcription* , 1998, The Journal of Biological Chemistry.

[2]  Xiao-Hong Sun,et al.  ETS-Mediated Cooperation between Basic Helix-Loop-Helix Motifs of the Immunoglobulin μ Heavy-Chain Gene Enhancer , 1998, Molecular and Cellular Biology.

[3]  J. Schalken,et al.  Role of E boxes in the repression of E-cadherin expression. , 1997, Biochemical and biophysical research communications.

[4]  Martin Rosenberg,et al.  A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer , 1997, Oncogene.

[5]  P. Steinert,et al.  The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. , 1997, Nucleic acids research.

[6]  W. Birchmeier,et al.  Analysis of the E‐cadherin and P‐cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis , 1997, Molecular carcinogenesis.

[7]  T. Libermann,et al.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family , 1997, Molecular and cellular biology.

[8]  S. Frisch.  The epithelial cell default‐phenotype hypothesis and its implications for cancer , 1997, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  A. Woodard,et al.  Transcriptional defects underlie loss of E-cadherin expression in breast cancer. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[10]  B. Vandenbunder,et al.  The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[11]  R. Sutherland,et al.  Expression of the PEA3 group of ETS‐related transcription factors in human breast‐cancer cells , 1997, International journal of cancer.

[12]  C. Bierkamp,et al.  Cadherins and catenins in development. , 1996, Current opinion in cell biology.

[13]  R Kemler,et al.  A role for cadherins in tissue formation. , 1996, Development.

[14]  E. Lengyel,et al.  Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences (*) , 1996, The Journal of Biological Chemistry.

[15]  P. Steinert,et al.  The Proximal Promoter of the Human Transglutaminase 3 Gene , 1996, The Journal of Biological Chemistry.

[16]  F. Higashino,et al.  A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. , 1996, Oncogene.

[17]  W. Birchmeier,et al.  Mechanisms Identified in the Transcriptional Control of Epithelial Gene Expression (*) , 1996, The Journal of Biological Chemistry.

[18]  M. Vijver,et al.  E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.

[19]  A. McMahon,et al.  Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. , 1995, Genes & development.

[20]  J. Herman,et al.  E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. , 1995, Cancer research.

[21]  J. Inazawa,et al.  ERM, a PEA3 Subfamily of Ets Transcription Factors, Can Cooperate with c-Jun (*) , 1995, The Journal of Biological Chemistry.

[22]  W. Birchmeier,et al.  Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. , 1995, Oncogene.

[23]  S. Hirohashi,et al.  Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Pankov,et al.  AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells , 1994, Molecular and cellular biology.

[25]  B. Vandenbunder,et al.  Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. , 1994, Cancer research.

[26]  J. Schalken,et al.  Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter. , 1994, Biochemical and biophysical research communications.

[27]  J. Brady,et al.  Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through an inverted CACCC motif and regulates promoter activity in cooperation with Ets1. , 1994, The Journal of biological chemistry.

[28]  H. Höfler,et al.  E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. , 1994, Cancer research.

[29]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[30]  P. Defossez,et al.  Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. , 1994, Oncogene.

[31]  A. Berchuck,et al.  Mutations of the E–cadherin gene in human gynecologic cancers , 1994, Nature Genetics.

[32]  C. Glass,et al.  Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene , 1994, Molecular and cellular biology.

[33]  W. Muller,et al.  PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. , 1993, Oncogene.

[34]  M. Takeichi.  Cadherins in cancer: implications for invasion and metastasis. , 1993, Current opinion in cell biology.

[35]  M. Tymms,et al.  The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Quintanilla,et al.  Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. , 1993, The American journal of pathology.

[37]  J. Ghysdael,et al.  Synergistic activation of the HTLV1 LTR Ets‐responsive region by transcription factors Ets1 and Sp1. , 1993, The EMBO journal.

[38]  S. McKnight,et al.  Specificities of protein-protein and protein-DNA interaction of GABP alpha and two newly defined ets-related proteins. , 1992, Genes & development.

[39]  W. Isaacs,et al.  Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.

[40]  J. Hassell,et al.  Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. , 1992, Genes & development.

[41]  B. Wasylyk,et al.  Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family. , 1992, Oncogene.

[42]  W. Birchmeier,et al.  The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Ringwald,et al.  The structure of the gene coding for the mouse cell adhesion molecule uvomorulin. , 1991, Nucleic acids research.

[44]  A. Balmain,et al.  Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. , 1991, Oncogene.

[45]  M. Quintanilla,et al.  A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis , 1991, The Journal of cell biology.

[46]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[47]  W. Birchmeier,et al.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.

[48]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[49]  B. Wasylyk,et al.  The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation , 1990, Nature.

[50]  B. Graves,et al.  Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus. , 1990, Genes & development.

[51]  Thomas J. White,et al.  PCR protocols: a guide to methods and applications. , 1990 .

[52]  B. Wold,et al.  In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. , 1990, Science.

[53]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .